Trace determination of lenalidomide in plasma by non-extractive HPLC procedures with fluorescence detection after pre-column derivatization with fluorescamine

BACKGROUND: Lenalidomide (LND) is a new potent drug used for treatment of multiple myeloma. For its pharmacokinetic studies and therapeutic monitoring, a proper analytical method was required. RESULTS: In this study, a non extractive and simple pre-column derivatization procedures have been proposed...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Khalil, Nasr Y, Darwish, Ibrahim A, Wani, Tanveer A, Al-Majed, Abdel-Rahman A
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2013
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3618069/
https://ncbi.nlm.nih.gov/pubmed/23497635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1752-153X-7-52
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller